The suhB gene of Burkholderia cenocepacia is required for protein secretion, biofilm formation, motility and polymyxin B resistance

Microbiology (United Kingdom)

Volumn 158, Issue 9, 2012, Pages 2315-2324

  Rosales Reyes, Roberto ^a,b   Saldías, María Soledad ^a   Aubert, Daniel F ^a   El Halfawy, Omar M ^a,c   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; KANAMYCIN; POLYMYXIN B;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BIOFILM; BURKHOLDERIA CENOCEPACIA; CELL MOTILITY; CONTROLLED STUDY; GENE; GENE DELETION; GENETIC SUSCEPTIBILITY; MUTANT; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN SECRETION; SUHB GENE; TYPE II SECRETION SYSTEM; TYPE IV SECRETION SYSTEM;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BIOFILMS; BURKHOLDERIA CENOCEPACIA; DRUG RESISTANCE, BACTERIAL; GENE DELETION; HUMANS; LOCOMOTION; POLYMYXIN B;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 84865680717     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.060988-0     Document Type: Article

References (54)

1. Abdulrahman, B. A., Khweek, A.A., Akhter, A., Caution, K., Kotrange, S., Abdelaziz, D. H., Newland, C., Rosales-Reyes, R., Kopp, B. & other authors (2011). Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy 7, 1359-1370.
2. Aubert, D. F., Flannagan, R. S. & Valvano, M. A. (2008). A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun 76, 1979-1991.
3. Aubert, D., MacDonald, D. K. & Valvano, M. A. (2010). BcsKC is an essential protein for the type VI secretion system activity in Burkholderia cenocepacia that forms an outer membrane complex with BcsLB. J Biol Chem 285, 35988-35998.
4. Buroni, S., Pasca, M. R., Flannagan, R. S., Bazzini, S., Milano, A., Bertani, I., Venturi, V., Valvano, M. A. & Riccardi, G. (2009). Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 9, 200.
5. Cascales, E. (2008). The type VI secretion toolkit. EMBO Rep 9, 735-741.
6. Chang, S. F., Ng, D., Baird, L. & Georgopoulos, C. (1991). Analysis of an Escherichia coli dnaB temperature-sensitive insertion mutation and its cold-sensitive extragenic suppressor. J Biol Chem 266, 3654-3660.
7. Chen, L. & Roberts, M. F. (2000). Overexpression, purification, and analysis of complementation behavior of E. coli SuhB protein: comparison with bacterial and archaeal inositol monophosphatases. Biochemistry 39, 4145-4153.
8. Coenye, T. & Vandamme, P. (2003). Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol 5, 719-729.
9. Cox, G. W., Mathieson, B. J., Gandino, L., Blasi, E., Radzioch, D. & Varesio, L. (1989). Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 81, 1492-1496.
10. Craig, F. F., Coote, J. G., Parton, R., Freer, J. H. & Gilmour, N. J. (1989). A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J Gen Microbiol 135, 2885-2890.
11. Eisenberg, F., Jr (1967). D-Myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis. J Biol Chem 242, 1375-1382.
12. Figurski, D. H. & Helinski, D. R. (1979). Replication of an origincontaining derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76, 1648-1652.
13. Flannagan, R. S., Linn, T. & Valvano, M. A. (2008). A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ Microbiol 10, 1652-1660.
14. Flannagan, R. S., Jaumouillé, V., Huynh, K. K., Plumb, J. D., Downey, G. P., Valvano, M. A. & Grinstein, S. (2012). Burkholderia cenocepacia disrupts host cell actin cytoskeleton by inactivating Rac and Cdc42. Cell Microbiol 14, 239-254.
15. González-Silva, N., López-Lara, I. M., Reyes-Lamothe, R., Taylor, A. M., Sumpton, D., Thomas-Oates, J. & Geiger, O. (2011). The dioxygenase-encoding olsD gene from Burkholderia cenocepacia causes the hydroxylation of the amide-linked fatty acyl moiety of ornithinecontaining membrane lipids. Biochemistry 50, 6396-6408.
16. Guide, S. V., Stock, F., Gill, V. J., Anderson, V. L., Malech, H. L., Gallin, J. I. & Holland, S. M. (2003). Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J Infect Dis 187, 845-853.
17. Hamad, M. A., Skeldon, A. M. & Valvano, M. A. (2010). Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol 76, 3170-3176.
18. Huber, B., Riedel, K., Köthe, M., Givskov, M., Molin, S. & Eberl, L. (2002). Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111. Mol Microbiol 46, 411-426.
19. Hunt, T. A., Kooi, C., Sokol, P. A. & Valvano, M. A. (2004). Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72, 4010-4022.
20. Huynh, K. K., Plumb, J. D., Downey, G. P., Valvano, M. A. & Grinstein, S. (2010). Inactivation of macrophage Rab7 by Burkholderia cenocepacia. J Innate Immun 2, 522-533.
21. Inada, T. & Nakamura, Y. (1995). Lethal double-stranded RNA processing activity of ribonuclease III in the absence of SuhB protein of Escherichia coli. Biochimie 77, 294-302.
22. Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P. & Levison, H. (1984). Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104, 206-210.
23. Ito, K., Wittekind, M., Nomura, M., Shiba, K., Yura, T., Miura, A. & Nashimoto, H. (1983). A temperature-sensitive mutant of E. coli exhibiting slow processing of exported proteins. Cell 32, 789-797.
24. Jani, A. J. & Cotter, P. A. (2010). Type VI secretion: not just for pathogenesis anymore. Cell Host Microbe 8, 2-6.
25. Keith, K. E., Hynes, D. W., Sholdice, J. E. & Valvano, M. A. (2009). Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia. Microbiology 155, 1004-1015.
26. Kooi, C. & Sokol, P. A. (2009). Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology 155, 2818-2825.
27. Kooi, C., Corbett, C. R. & Sokol, P. A. (2005). Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease. J Bacteriol 187, 4421-4429.
28. Kooi, C., Subsin, B., Chen, R., Pohorelic, B. & Sokol, P. A. (2006). Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun 74, 4083-4093.
29. Kozloff, L. M., Turner, M. A., Arellano, F. & Lute, M. (1991). Phosphatidylinositol, a phospholipid of ice-nucleating bacteria. J Bacteriol 173, 2053-2060.
30. Lamothe, J., Huynh, K. K., Grinstein, S. & Valvano, M. A. (2007). Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol 9, 40-53.
31. Loutet, S. A. & Valvano, M. A. (2010). A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 78, 4088-4100.
32. Loutet, S. A., Flannagan, R. S., Kooi, C., Sokol, P. A. & Valvano, M. A. (2006). A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188, 2073-2080.
33. Loutet, S. A., Bartholdson, S. J., Govan, J. R., Campopiano, D. J. & Valvano, M. A. (2009). Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia. Microbiology 155, 2029-2039.
34. Mahenthiralingam, E., Urban, T. A. & Goldberg, J. B. (2005). The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144-156.
35. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
36. Marolda, C. L., Lahiry, P., Vinés, E., Saldías, S. & Valvano, M. A. (2006). Micromethods for the characterization of lipid A-core and Oantigen lipopolysaccharide. Methods Mol Biol 347, 237-252.
37. Matsuhisa, A., Suzuki, N., Noda, T. & Shiba, K. (1995). Inositol monophosphatase activity from the Escherichia coli suhB gene product. J Bacteriol 177, 200-205.
38. Michell, R. H. (2011). Inositol and its derivatives: their evolution and functions. Adv Enzyme Regul 51, 84-90.
39. Miller, V. L. & Mekalanos, J. J. (1988). A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170, 2575-2583.
40. Movahedzadeh, F., Wheeler, P. R., Dinadayala, P., Av-Gay, Y., Parish, T., Daffé, M. & Stoker, N. G. (2010). Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis. BMC Microbiol 10, 50.
41. Munnik, T. & Nielsen, E. (2011). Green light for polyphosphoinositide signals in plants. Curr Opin Plant Biol 14, 489-497.
42. Parish, T., Liu, J., Nikaido, H. & Stoker, N. G. (1997). A Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeability. J Bacteriol 179, 7827-7833.
43. Paulus, H. & Kennedy, E. P. (1960). The enzymatic synthesis of inositol monophosphatide. J Biol Chem 235, 1303-1311.
44. Pukatzki, S., McAuley, S. B. & Miyata, S. T. (2009). The type VI secretion system: translocation of effectors and effector-domains. Curr Opin Microbiol 12, 11-17.
45. Rosales-Reyes, R., Skeldon, A. M., Aubert, D. F. & Valvano, M. A. (2012). The type VI secretion system of Burkholderia cenocepacia affects multiple Rho family GTPases disrupting the actin cytoskeleton and the assembly of NADPH oxidase complex in macrophages. Cell Microbiol 14, 255-273.
46. Saldías, M. S. & Valvano, M. A. (2009). Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 155, 2809-2817.
47. Schmerk, C. L., Bernards, M. A. & Valvano, M. A. (2011). Hopanoid production is required for low-pH tolerance, antimicrobial resistance, and motility in Burkholderia cenocepacia. J Bacteriol 193, 6712-6723.
48. Shewan, A., Eastburn, D. J. & Mostov, K. (2011). Phosphoinositides in cell architecture. Cold Spring Harb Perspect Biol 3, a004796.
49. Shiba, K., Ito, K. & Yura, T. (1984a). Mutation that suppresses the protein export defect of the secY mutation and causes cold-sensitive growth of Escherichia coli. J Bacteriol 160, 696-701.
50. Shiba, K., Ito, K., Yura, T. & Cerretti, D. P. (1984b). A defined mutation in the protein export gene within the spc ribosomal protein operon of Escherichia coli: isolation and characterization of a new temperature-sensitive secY mutant. EMBO J 3, 631-635.
51. Shiba, K., Ito, K. & Yura, T. (1986). Suppressors of the secY24 mutation: identification and characterization of additional ssy genes in Escherichia coli. J Bacteriol 166, 849-856.
52. Sokol, P. A., Ohman, D. E. & Iglewski, B. H. (1979). A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa. J Clin Microbiol 9, 538-540.
53. Wang, Y., Stieglitz, K. A., Bubunenko, M., Court, D. L., Stec, B. & Roberts, M. F. (2007). The structure of the R184A mutant of the inositol monophosphatase encoded by suhB and implications for its functional interactions in Escherichia coli. J Biol Chem 282, 26989-26996.
54. Waters, V. & Ratjen, F. (2006). Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues. Expert Rev Anti Infect Ther 4, 807-819.